Objective: To assess the efficacy and safety profile of docetaxel, as a single agent, in the treatment of elderly patients with advanced breast cancer. Methods: Twenty-eight patients, with a median ...

Experts project the diagnosis of over 300,000 prostate cancer cases in the United States in 2006, along with over 30,000 ...

Patients with prostate cancer who receive docetaxel with standard-of-care treatment may have a reduced risk of death and an improved prognosis, according to a recent study. Patients with prostate ...

Nubeqa plus androgen deprivation therapy and docetaxel to treat patients with metastatic hormone-sensitive prostate cancer lowered hospitalization rates but led to marginally longer lengths of stay ...

In this phase II trial, we attempted to combine full doses of docetaxel and vinorelbine with trastuzumab in the first-line treatment of patients with HER2-positive MBC. However, we found that delivery ...

PURPOSE: To evaluate the efficacy and toxicity of docetaxel administered weekly to elderly or poor-performance status patients with advanced breast cancer. PATIENTS AND METHODS: Forty-one patients ...

A combination of KN026, a novel bispecific antibody, and docetaxel elicited responses with an acceptable toxicity profile when administered as neoadjuvant treatment in patients with HER2-positive ...

Patients who received gemcitabine followed by docetaxel experienced a delay in the need for radical cystectomy. Sequential intravesical gemcitabine/docetaxel treatment for high-risk nonmuscle-invasive ...

Researchers have identified a receptor protein known as CHRM1 as a key player in prostate cancer cells' resistance to docetaxel, a commonly used chemotherapy drug to treat advanced cancer that has ...

Increasing Mixed Chimerism Is an Important Prognostic Factor for Unfavorable Outcome in Children With Acute Lymphoblastic Leukemia After Allogeneic Stem-Cell Transplantation: Possible Role For ...

Results of Second Planned Interim Analysis of Phase III Study: BCIRG 006 SAN ANTONIO, Dec. 14 /PRNewswire-FirstCall/ -- The Cancer International Research Group (CIRG ...